Ethylbromazolam – For scientific and informational purposes only
Ethylbromazolam is a triazolobenzodiazepine derivative described in pharmacological and toxicological literature due to its high affinity for GABA.A_AAreceptor. The compound is being studied in research settings to analyse structural variations within the benzodiazepine class and to investigate the relationship between chemical substituents and receptor potency. Ethylbromazolam is intended solely for scientific documentation and laboratory analysis, and is not suitable for consumption or application outside of a controlled research context.
Ethylbromazolam should be stored in a dry, cool environment and in a tightly sealed container. Benzodiazepine derivatives are sensitive to light and degradation when exposed to moisture. Under proper storage conditions, the compound typically remains stable for analytical purposes for 1 to 2 years. Consult the material safety data sheet (MSDS) for any additional storage instructions.
- Synonym: Ethyl bromazolam
- CAS number: 105470-75-5
- Chemical formula: C₁₇H₁₆BrN₅
- Molar mass: ± 388.25 g/mol
- Classification: Triazolobenzodiazepine
- Purity: Depending on reference source or analysis method used
- Keep out of reach of children and pets.
- Avoid contact with eyes, skin and respiratory tract.
- Do not discharge into the environment.
- Handle only within a suitable laboratory environment with appropriate personal protective equipment.
• Always consult the available safety documentation (MSDS) before using the substance.
Ethylbromazolam is a pharmacologically active and potentially controlled benzodiazepine analogue. Improper handling or exposure may cause significant health risks. The substance is not suitable for consumption or application without medical or legal supervision. Strictly adhere to all relevant health, safety, and legal guidelines during laboratory use.